Finanical Statements
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 31/03/2026
Published at 17 May 2026 at 10:46Related stock: PHAR
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name: Egyptian International Pharmaceuticals (EIPICO)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 268,960,528
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,999,555
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The Standalone Financial Statements in Arabic (3,796 KB)
The BoD Report in Arabic (287 KB)
The BoD Report in English (160 KB)
The Standalone Financial Statements in English (4,052 KB)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 268,960,528
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,999,555
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The Standalone Financial Statements in Arabic (3,796 KB)
The BoD Report in Arabic (287 KB)
The BoD Report in English (160 KB)
The Standalone Financial Statements in English (4,052 KB)